Genomed Inc

Genomind was founded over a decade ago by Dr. Our mission is to optimize the treatment experience for individuals and healthcare providers by unlocking the value of precision medicine through actionable genetic insights and innovative health technology. We are responsible to uphold our commitments to our employees, partners, and patients in need of care throughout the world. Genomind brings critical prescribing data into one integrated platform, so you can easily manage medications for individual patients or large populations with precision. Register for Genomind’s upcoming clinical education webinar on utilizing medical cannabis in clinical pharmacology. D set out to make that vision a reality by establishing Genomind as one of the first mental health focused pharmacogenetic testing services. Today, PGx is increasingly recognized as a valid and effective tool for the delivery of quality psychiatric care. There is no one-size-fits all treatment, and Genomind’s platform was developed to unlock the potential of truly personalized medicine.

Diagnomics envisions a future where cooperation between patients, physicians, and scientists enables a truly personalized medicine which recognizes patients as unique individuals and arms them with more accurate information about their genetic make-up. We are at the dawn of a new era in personalized medicine which allows us to use more effective therapies and treatments based on better insight into disease and personal health. Our vision is to develop complete solutions for personal genome profiling, sequencing and annotation, with the ultimate goal of integrating individual genomic sequencing into routine medical care. Diagnomics seeks to embrace the incredibly bright and hopeful future that personalized medicine provides, leading to improving individual well being. Diagnomics has a highly qualified team of scientists including early pioneers in sequencing the human genome. Additionally, Diagnomics has cutting edge genome presentation software as well as genome discovery expertise to guide the development of novel diagnostic tools and new therapeutic targets. Diagnomics opened its CLIA laboratory in 2016 and is accredited by the California Department of Public Health (CDPH). Established in 2011, Diagnomics is one of the first Next Generation Sequencing (NGS)-based genomics companies located in California.

Our mission is to provide the best validated disease models and comprehensive preclinical capabilities with an innovative drug screening technology and a development-stage drug candidate.Through our 10+ years of experience, our team of talented scientists have developed innovative AI-driven drug discovery platforms and analytical tools leading to partnerships and numerous drug candidates in clinical trials. GeN is a drug discovery and pre-clinical validation company with expertise in CNS and orphan disorders.

GENEdiagnostics (Pty) Ltd is a leading genetic testing, research and training business, dedicated to providing a comprehensive, cost-effective service throughout South Africa and the rest of Africa. We provide a full range of genetic tests at a competitive price accompanied by valuable feedback and advice to healthcare professionals, which assists them in managing their patients’ medical conditions. GENEdiagnostics provides training and research services to both the private and public sectors. We are continuously innovating and developing new genetic tests to take to market, with the aim of improving the quality of life of individual, and communities of individuals. GENEdiagnostics is 100% Black-owned and the only Black-owned genetics service provider. The company was established ten years ago by Professor Monique Zaahl and has developed an enviable reputation for the excellent quality of our technical expertise and our customer focused culture.

GMDx Genomics is a genomic testing company using machine learning (ML) and patented algorithms to provide a comprehensive and individualized Innate Immune Fitness (IIF) profile. The GMDx enabling platform utilises an industry-leading framework developed by stack partners Applied Precision Medicine that is built on the Oracle Autonomous Cloud.

Genknowme (dʒɨˈnoʊmi) has been founded in 2019 by a team of passionate scientists. We provide a novel blood test to support healthcare professionals while they coach their patients into making healthy lifestyle changes. Genknowme is one of the few innovative companies participating in this epigenetic revolution where epigenetic assessment will soon have predictive or prognostic value for therapy and will be decisive in therapeutic decision-making. Genknowme’s vision is to provide a health assessment that encompasses all factors influencing premature aging and good health, to provide health professionals with the means to guide their patients on the path of self-knowledge regarding their health. Florian strategically advises Genknowme, and oversees the administration since the incorporation. We provide a novel blood test to support healthcare professionals while they coach their patients into making healthy lifestyle changes. Genknowme measures the impact of your lifestyle at DNA level by determining your biological age with epigenetic assessment. We provide the fastest, most accurate and comprehensive epigenetic health assessment on the market.